BHST (BioHarvest Sciences) Earnings per share growth rate in current year
The commercialization of the bio-cell growth platform creates positive momentum for BioHarvest Sciences (BHST), as confirmed by the YoY earnings per share dynamics, where 6.40 is recorded as the baseline value. However, scaling production and market adoption of the product remain challenging tasks. Additional pressure is created by geopolitical tensions, which disrupt the export of ingredients and increase raw material procurement costs due to inflation.
Analytical breakdowns and data insights for company BioHarvest Sciences Inc (BHST)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Total Debt to Capital Coefficient BioHarvest Sciences|BHST - Long-Term Debt to Equity|Current Liabilities to Capital BioHarvest Sciences Inc.|BHST - Company Aggregate Debts|Debt to Net Assets Ratio BioHarvest Sciences|BHST - Company Long-Term Debts|Company Short-Term Debts BioHarvest Sciences|Intermediate Coverage Ratio bioharvest.com
- net income and valuation multiples indicators:
BHST - Net Income|Expected Profit BioHarvest Sciences|BHST - P/E Multiple|Projected Price to Earnings Ratio bioharvest.com|BHST - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio BioHarvest Sciences, Inc.|BHST - Operating profit before deduction of amortization|Earnings per share for the last four quarters BioHarvest Sciences|BHST - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months bioharvest.com|BHST - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year BioHarvest Sciences
- sales volume and revenue information:
Fundamental valuation:BioHarvest (BHST)
BioHarvest Sciences (BHST) is strengthening its position in the biotechnology sector by scaling VINIA sales and expanding into the US market. Year-over-year EPS dynamics quantify the effectiveness of this strategy by measuring the percentage change in net income per share, allowing investors to distinguish real capital growth from speculative expectations while assessing the fundamental resilience of the business via this trend.
Direct competitors
Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Expected net earnings per share growth this year liquidia.com LQDA|Galapagos (GLPG) - Earnings per share growth in current year|ANIP - Expected net earnings per share growth this year|Earnings per share growth in current year MannKind Corporation|AMPH: Earnings per share increase in current year|Earnings per share growth in current year Pacira BioSciences (PCRX)|SPRY: Earnings per share trend in current year|Theravance Biopharma, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year AQST (Aquestive Therapeutics, Inc.)|SCPH - Earnings per share growth in current year|Expected net earnings per share growth this year tectonictx.com TECX|TNXP: Earnings growth in current year|Earnings per share growth this year SXTC|Net earnings per share growth this year EPRX|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals
